Translations:SGLT2 inhibitor/3/en

Revision as of 19:46, 12 February 2024 by FuzzyBot (talk | contribs) (Importing a new version from external source)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Medical uses

The 2022 ADA standards of medical care in diabetes include SGLT2 inhibitors as a first line pharmacological therapy for type 2 diabetes (usually together with metformin), specifically in patients with chronic kidney disease, cardiovascular disease or heart failure.

Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:SGLT2_inhibitor/3/en&oldid=113832"